Unknown

Dataset Information

0

Host Genome Variation is Associated with Neurocognitive Outcome in Survivors of Pediatric Medulloblastoma.


ABSTRACT: Host genome analysis is a promising source of predictive information for long-term morbidity in cancer survivors. However, studies on genetic predictors of long-term outcome, particularly neurocognitive function following chemoradiation in pediatric oncology, are limited. Here, we evaluated variation in host genome of long-term survivors of medulloblastoma and its association with neurocognitive outcome. Whole-genome sequencing was conducted on peripheral blood of long-term survivors of pediatric medulloblastoma who also completed neuropsychological testing. Cognitively impaired and less impaired survivors did not differ in exposure to chemoradiation therapy or age at treatment. Unsupervised consensus clustering yielded two distinct variant clusters that were significantly associated with neurocognitive outcome. Interestingly, 34 of the 36 significant variants were found in noncoding DNA regions with unknown regulatory function. A separate unsupervised cluster analysis of variants within DNA repair genes identified discrete variant groups that were not associated with neurocognitive outcome, suggesting that variations in genes corresponding to a single functional group may be insufficient to predict long-term outcome alone. These findings are supportive of the presence of a genetic diathesis for treatment-related neurocognitive morbidity in medulloblastoma that may be driven by variation in noncoding regulatory elements.

SUBMITTER: Siegel BI 

PROVIDER: S-EPMC6515414 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Host Genome Variation is Associated with Neurocognitive Outcome in Survivors of Pediatric Medulloblastoma.

Siegel Benjamin I BI   King Tricia Z TZ   Rupji Manali M   Dwivedi Bhakti B   Carter Alexis B AB   Kowalski Jeanne J   MacDonald Tobey J TJ  

Translational oncology 20190509 7


Host genome analysis is a promising source of predictive information for long-term morbidity in cancer survivors. However, studies on genetic predictors of long-term outcome, particularly neurocognitive function following chemoradiation in pediatric oncology, are limited. Here, we evaluated variation in host genome of long-term survivors of medulloblastoma and its association with neurocognitive outcome. Whole-genome sequencing was conducted on peripheral blood of long-term survivors of pediatri  ...[more]

Similar Datasets

| EGAS00001002996 | EGA
| S-EPMC8216078 | biostudies-literature
| S-EPMC7387137 | biostudies-literature
| S-EPMC5663794 | biostudies-literature
| S-EPMC4722086 | biostudies-literature
| S-EPMC4724248 | biostudies-literature
| S-EPMC7317774 | biostudies-literature
| S-EPMC5814510 | biostudies-literature
| S-EPMC4121535 | biostudies-literature
| S-EPMC8249306 | biostudies-literature